Workflow
均普智能(688306) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥452,543,090.16, a decrease of 12.19% compared to the same period last year[2]. - The net profit attributable to shareholders was -¥18,371,371.96, with a year-to-date loss of -¥48,766,970.48[2]. - The net profit attributable to shareholders for the current reporting period is -18.37 million yuan, with a year-on-year loss reduction of 70.75%[7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is -18.77 million yuan, with a year-on-year loss reduction of 65.86%[7]. - The basic earnings per share for the current period is -0.4877 yuan, with a year-on-year loss reduction of 45.08%[7]. - Net profit for the third quarter of 2024 was -¥51,301,902.38, an improvement from -¥88,801,315.80 in the same quarter of 2023[22]. - Total comprehensive income attributable to the parent company for Q3 2024 was -45,747,510.50 RMB, compared to -71,412,618.54 RMB in Q3 2023[23]. Revenue and Orders - The total amount of new orders signed in the first three quarters was ¥1,179,000,000, with a backlog of orders totaling ¥3,817,000,000[4]. - Total operating revenue for the first three quarters of 2024 reached ¥1,572,717,927.33, an increase of 4.14% compared to ¥1,510,162,554.24 in the same period of 2023[20]. - The company signed new orders worth RMB 1.179 billion in Q3 2024, with total orders on hand reaching RMB 3.817 billion[15]. Costs and Expenses - Total operating costs for the first three quarters of 2024 were ¥1,648,652,345.79, up from ¥1,595,330,478.64 in 2023, reflecting a year-on-year increase of 3.34%[20]. - Research and development expenses for the quarter were ¥12,617,909.01, a decrease of 32.49% year-on-year[3]. - Research and development expenses for the third quarter of 2024 amounted to ¥44,725,767.76, down 22.54% from ¥57,780,353.10 in the previous year[22]. Cash Flow - The net cash flow from operating activities was ¥54,257,138.95, although it decreased by 55.28% year-on-year[2]. - Cash flow from operating activities for the first three quarters of 2024 was 54,257,138.95 RMB, down from 121,313,310.60 RMB in the same period of 2023[24]. - Cash inflow from operating activities totaled 1,928,621,035.70 RMB in the first three quarters of 2024, compared to 2,062,386,584.02 RMB in 2023[24]. - Cash outflow for purchasing goods and services was 989,658,637.90 RMB in the first three quarters of 2024, down from 1,171,360,825.74 RMB in 2023[24]. - Cash flow from investing activities generated a net inflow of 104,150,860.48 RMB in the first three quarters of 2024, compared to 53,248,286.35 RMB in 2023[25]. - Cash flow from financing activities resulted in a net outflow of -133,995,767.57 RMB in the first three quarters of 2024, compared to a net inflow of 20,450,696.01 RMB in 2023[25]. Assets and Liabilities - Total assets at the end of the reporting period were ¥5,098,839,071.28, a decrease of 1.10% from the end of the previous year[3]. - The total assets of the company as of the end of the third quarter of 2024 were ¥5,098,839,071.28, a decrease from ¥5,155,727,500.89 at the end of the third quarter of 2023[20]. - Total liabilities increased to ¥3,367,243,708.77 in the third quarter of 2024, compared to ¥3,330,768,970.09 in the same period of 2023[20]. - The company's total non-current liabilities were ¥799,179,320.67, a decrease from ¥839,649,995.27 in the same period of 2023[20]. - The company's total equity attributable to shareholders was ¥1,731,595,362.51, down from ¥1,829,336,026.77 in the same period of 2023[20]. Government Support and Strategic Initiatives - The company received government subsidies amounting to ¥576,174.61 during the reporting period[5]. - The company aims to enhance profitability and maximize shareholder value through project management optimization and global business layout adjustments[4]. - The company has optimized its global business layout, focusing on high-yield sectors[7]. - The company has strengthened its accounts receivable recovery efforts, leading to a decrease in credit impairment losses[10]. Research and Development - The company is focusing on R&D in machine vision systems, optical devices, and CCS connection systems to enhance automation in various industries[16]. - The company has filed a total of 146 patents, including 39 invention patents and 66 software copyrights[16]. - The company is developing a platform cam technology for insulin injection pens, achieving a production cycle of 1.5 seconds per unit[15]. - The company has launched the Jarvis 2.0 humanoid robot, continuing to iterate on its previous model[16]. - The company is collaborating with a leading insulin pen manufacturer to develop efficient assembly technologies for medical devices[15]. Inventory and Receivables - The company's inventory increased to RMB 2.070 billion from RMB 1.931 billion year-on-year[18]. - The company reported a decrease in accounts receivable to RMB 254.31 million from RMB 358.42 million year-on-year[18]. - The company reported a significant increase in other receivables by 351.67%, mainly due to tax refunds and increased employee advances[8]. Shareholder Actions - The company has repurchased shares, resulting in an increase in treasury stock by 995.81%[8]. - The company's cash and cash equivalents decreased, with short-term borrowings at ¥157,793,878.18, down from ¥189,853,578.08 in the previous year[20]. - As of September 30, 2024, the company's cash and cash equivalents amounted to RMB 785.27 million, an increase from RMB 776.99 million at the end of 2023[18].